SEC Form 4 · accession 0001711576-26-000002
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Walters-Hoffert
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001372514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.63 | Jun 10, 2026 | A | 25,000 | A | Jun 10, 2027 | Jun 10, 2036 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027.